The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction: Effect of Angiotensin II Receptor Blockade and Role in Cardiac Fibrosis
Open accessAbstract
Background —This study analyzed the regulation and the role of the cardiac steroidogenic system in myocardial infarction (MI). Methods and Results —Seven days after MI, rats were randomized to untreated infarcted group or spironolactone- (20 and 80 mg · kg −1 · d −1 ), losartan- (8 mg · kg −1 · d −1 ), spironolactone plus losartan–, and L-NAME– (5 mg · kg −1 · d −1 ) treated infarcted groups for 25 days. Sham-operated rats served as controls. In the noninfarcted myocardium of the left ventricle (LV), MI raised aldosterone synthase mRNA (the terminal enzyme of aldosterone synthesis) by 2.0-fold and the aldosterone level by 3.7-fold. Conversely, MI decreased 11β-hydroxylase mRNA (the terminal enzyme of corticosterone synthesis) by 2.4-fold and the corticosterone level by 1.9-fold. MI also induced a 1.9-fold increase in cardiac angiotensin II level. Such cardiac regulations were completely prevented by treatment of the infarcted heart with losartan. The MI-induced collagen deposition in noninfarcted LV myocardium was prevented by 1.6-fold by both low and high doses of spironolactone and by 2.5-fold by losartan. In addition, norepinephrine level was unchanged in infarcted heart but was attenuated by both losartan and spironolactone treatments. Conclusions —MI is associated with tissue-specific activation of myocardial aldosterone synthesis. This increase is mediated primarily by cardiac angiotensin II via AT 1 -subtype receptor and may be involved in post-MI ventricular fibrosis and in control of tissue norepinephrine concentration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Myocardial infarct size and ventricular function in rats.
Pfeffer, M. A., Pfeffer, J. M., Fishbein, M. C., Fletcher, P. J., Spadaro, J., Kloner, R. A., & Braunwald, E. (1979) · Circulation Research · doi:10.1161/01.res.44.4.503 · Cited by 1,281
Remodeling of the rat right and left ventricles in experimental hypertension.
Brilla, C. G., Pick, R., Tan, L. B., Janicki, J. S., & Weber, K. T. (1990) · Circulation Research · doi:10.1161/01.res.67.6.1355 · Cited by 674
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.
Hirsch, A. T., Talsness, C. E., Schunkert, H., Paul, M., & Dzau, V. J. (1991) · Circulation Research · doi:10.1161/01.res.69.2.475 · Cited by 458
Myocardial Production of Aldosterone and Corticosterone in the Rat
Silvestre, J.-S., Robert, V., Heymes, C., Aupetit-Faisant, B., Mouas, C., Moalic, J.-M., Swynghedauw, B., & Delcayre, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4883 · Cited by 446
Self-citationSchieffer, B., Wirger, A., Meybrunn, M., Seitz, S., Holtz, J., Riede, U. N., & Drexler, H. (1994) · Circulation · doi:10.1161/01.cir.89.5.2273 · Cited by 420
Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain
Mellon, S. H., & Deschepper, C. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91332-m · Cited by 398
The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex
Curnow, K. M., Tusie-Luna, M.-T., Pascoe, L., Natarajan, R., Gu, J.-L., Nadler, J. L., & White, P. C. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1513 · Cited by 362
GLUCOCORTICOID AND MINERALOCORTICOID RECEPTORS: Biology and Clinical Relevance
Funder, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.231 · Cited by 320
Barr, C. S., Lang, C. C., Hanson, J., Arnott, M., Kennedy, N., & Struthers, A. D. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80353-1 · Cited by 318
Hatakeyama, H., Miyamori, I., Fujita, T., Takeda, Y., Takeda, R., & Yamamoto, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51084-5 · Cited by 316
Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor
Kudo, T., & Baird, A. (1984) · Nature · doi:10.1038/312756a0 · Cited by 225
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction.
Michel, J. B., Lattion, A. L., Salzmann, J. L., Cerol, M. L., Philippe, M., Camilleri, J. P., & Corvol, P. (1988) · Circulation Research · doi:10.1161/01.res.62.4.641 · Cited by 222
Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat
Sun, Y., Cleutjens, J. P. M., Diaz-Arias, A. A., & Weber, K. T. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.9.1423 · Cited by 198
Lindpaintner, K., Lu, W., Niedermajer, N., Schieffer, B., Just, H., Ganten, D., & Drexler, H. (1993) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1993.1017 · Cited by 194
Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.
Robert, V, Van Thiem, N., Cheav, S. L., Mouas, C., Swynghedauw, B., & Delcayre, C. (1994) · Hypertension · doi:10.1161/01.hyp.24.1.30 · Cited by 180
Self-citationBiological Determinants of Aldosterone-Induced Cardiac Fibrosis in Rats
Robert, V., Silvestre, J.-S., Charlemagne, D., Sabri, A., Trouvé, P., Wassef, M., Swynghedauw, B., & Delcayre, C. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.971 · Cited by 174
Self-citationTakeda, Y. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2797 · Cited by 169
Wollert, K. C., Studer, R., von Bülow, B., & Drexler, H. (1994) · Circulation · doi:10.1161/01.cir.90.5.2457 · Cited by 121
Malee, M. P., & Mellon, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4731 · Cited by 66
High Affinity NAD+-dependent 11β-hydroxysteroid Dehydrogenase in the Human Heart
Slight, S. H. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0072 · Cited by 64
Escoubet, B., Coureau, C., Blot‐Chabaud, M., Bonvalet, J. P., & Farman, N. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1343 · Cited by 40
Volpe, M., Gigante, B., Enea, I., et al. (1997) · Circulation Research · doi:10.1161/01.res.81.5.857 · Cited by 32
Nakayama, T., Izumi, Y., Soma, M., & Kanmatsuse, K. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.157 · Cited by 11
Cited by
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Chronic Renal Failure after Transplantation of a Nonrenal Organ
Ojo, A. O., Held, P. J., Port, F. K., Wolfe, R. A., Leichtman, A. B., Young, E. W., Arndorfer, J., Christensen, L., & Merion, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021744 · Cited by 2,220
Left Ventricular Remodeling After Myocardial Infarction: Pathophysiology and Therapy
Sutton, M. G. S. J., & Sharpe, N. (2000) · Circulation · doi:10.1161/01.cir.101.25.2981 · Cited by 1,824
Aldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Burchfield, J. S., Xie, M., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001878 · Cited by 766
Metadata
- Authors
- Silvestre, J.-S., Heymes, C., Oubénaïssa, A., Robert, V., Aupetit-Faisant, B., Carayon, A., Swynghedauw, B., & Delcayre, C.
- Venue
- Circulation
- Published
- 1999-05-25
- Volume
- 99
- Issue
- 20
- Pages
- 2694-2701
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2058431890
- Cited by
- 380
- References
- 24
- FWCI
- 15.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.